← Back to Vaccine Database

MAGE-A3

Peptide based vaccine · VDDBV0465

Target & Classification

HPVHuman papillomavirus
Peptide based vaccine
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Phase 1

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials1

NCT IDPhaseDisease / Condition
NCT00257738 Phase 1Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8